News Quantified

ARRY – array technologies, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

ARRAY Technologies Bolsters Board With Two Additional Directors

Morgan Stanley Maintains an Equal Weight Rating on Array Technologies, Inc. (ARRY) [Yahoo! Finance]

UBS Lowers Array Technologies (ARRY) Price Target to $10 [Yahoo! Finance]

Assessing Array Technologies (ARRY) Valuation As Shares Show Mixed Short Term Momentum [Yahoo! Finance]

IRS Tax Window Puts Array Technologies Valuation And Momentum In Focus [Yahoo! Finance]

-33.8%

BEAT

0.6%

BEAT

-5.9%

BEAT

1.4%

BEAT

Form 8-K Array Technologies, Inc. For: Mar 19

Form 4 Array Technologies, Inc. For: Mar 12 Filed by: Zhu James

Form 4 Array Technologies, Inc. For: Mar 12 Filed by: Gunning Gina K

Form 4 Array Technologies, Inc. For: Mar 12 Filed by: Manning Neil

Form 4 Array Technologies, Inc. For: Mar 12 Filed by: Jennings H. Keith

Top News Gainers

5/21 Array BioPharma's colorectal cancer combo treatment meets main goals [Reuters (UK)] 28.9%

5/29 Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference 4.5%

6/3 Form 4 ARRAY BIOPHARMA INC For: May 30 Filed by: Sandor Victor 2.8%

5/23 Form 4 ARRAY BIOPHARMA INC For: May 21 Filed by: Sandor Victor 2.6%

5/7 Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 2.3%

5/10 Array Biopharma Inc (NASDAQ: ARRY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. 0.8%

7/25 Form SC 14D9/A ARRAY BIOPHARMA INC Filed by: ARRAY BIOPHARMA INC 0.8%

6/4 Array BioPharma to Present at the Goldman Sachs 40?? Annual Global Healthcare Conference 0.7%

7/29 Form SC TO-T/A ARRAY BIOPHARMA INC Filed by: PFIZER INC 0.7%

6/28 Form SC TO-T ARRAY BIOPHARMA INC Filed by: PFIZER INC 0.7%

Top News Decliners

5/7 Form 10-Q ARRAY BIOPHARMA INC For: Mar 31 -4.8%

5/28 Form 4 ARRAY BIOPHARMA INC For: May 23 Filed by: Sandor Victor -3.2%

6/17 Pfizer to Acquire Array BioPharma -2.1%

5/22 Array Biopharma Inc (NASDAQ: ARRY) had its price target raised by analysts at SunTrust Banks, Inc. to $32.00. They now have a "buy" rating on the stock. -1.4%

5/9 Array BioPharma to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference -1.0%

6/21 Financialbuzz.com: 'Market Recap' Week Ending June 21st, 2019 -0.6%

7/12 Array Biopharma Inc (NASDAQ: ARRY) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. -0.6%

6/18 Form SC TO-C ARRAY BIOPHARMA INC Filed by: PFIZER INC -0.6%

5/5 Array Biopharma Inc (NASDAQ: ARRY) was given a new $25.00 price target on by analysts at Cowen Inc. They now have a "buy" rating on the stock. -0.6%

7/12 Form SC 14D9/A ARRAY BIOPHARMA INC Filed by: ARRAY BIOPHARMA INC -0.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day